Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07155434 · ClinicalTrials.gov registry record
ENABLE-HCM - AI-ENabled Echocardiography With Ultrasound Beyond the Echo Lab for Better HCM Imaging and Expanded Access
A clinical trial, sponsored by UltraSight.
- Terminated
- Registry status
- 36
- Enrollment target
NCT07155434 is a clinical trial that was terminated before completion, run by UltraSight. The registered enrollment target is 36 participants.
The verdict
NCT07155434 was terminated before completion, sponsored by UltraSight.
- TERMINATED
- Registry status
- 36 participants
- Enrollment target
Study Summary
This study evaluates whether healthcare providers without specialized ultrasound training can use UltraSight's machine learning based Guidance Software to perform limited transthoracic echocardiography in patients with hypertrophic obstructive cardiomyopathy (HOCM), who are receiving or eligible for mavacamten (Camzyos™). Participants will undergo two heart scans on the same day, one by a non-sonographer using the software and one by a trained sonographer. The study aims to determine if the software-guided images are comparable in quality, with the goal of expanding access to heart monitoring for HCM patients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2025-07-25 |
| Est. Completion | 2026-02-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07155434
The ClinicalTrials.gov registry entry for NCT07155434 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UltraSight, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT07155434 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07155434 about?
NCT07155434 is a clinical study titled "ENABLE-HCM - AI-ENabled Echocardiography With Ultrasound Beyond the Echo Lab for Better HCM Imaging and Expanded Access". This study evaluates whether healthcare providers without specialized ultrasound training can use UltraSight's machine learning based Guidance Software to perform limited transthoracic echocardiography in patients with hypertrophic obstructive cardiomyopathy (HOCM), who are receiving or eligible for...
What is the current status of trial NCT07155434?
This trial is currently terminated. The enrollment target is 36 participants. The study started on 2025-07-25. Estimated completion is 2026-02-24.
Who is sponsoring clinical trial NCT07155434?
This trial is sponsored by UltraSight, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.